Navigation Links
Prasco Announces Agreement with Shire for Future Exclusive Distribution and Supply of Authorized Generic for PENTASA®
Date:2/22/2011

CINCINNATI, Feb. 22, 2011 /PRNewswire/ -- Prasco Laboratories announced today it has signed a distribution and supply agreement with Shire US Manufacturing, Inc. for mesalamine controlled-release capsules.  As part of the agreement, Prasco, LLC is prepared to market the authorized generic version of PENTASA® (mesalamine) Controlled-Release Capsules, at Shire's request, immediately upon any entrance into the United States market of an approved ANDA for any generic mesalamine product which is AB-rated to PENTASA®.  (At the present time, the FDA has not approved any ANDA for PENTASA®.)  The authorized generic will be marketed in the United States in 250 mg and 500 mg strengths under the Prasco label.

"We are excited to have established this new business relationship with Shire," stated Prasco Chief Executive Officer, E. Thomas Arington.  "Patients and pharmacists alike benefit when a company such as Shire commits to maintaining the supply of brand-identical medication through the Prasco Authorized Generic business model," Arington concluded.

PENTASA® is a registered trademark of Ferring A/S Corp.

About Prasco

Prasco is a privately-held pharmaceutical company located in Cincinnati, OH which specializes in Authorized Generics.  Prasco Authorized Generics provide brand pharmaceutical companies with a strategic lifecycle management solution. Prasco sells its product line through the major distribution channels, and operates from a cGMP compliant VAWD certified 160,000 sq. ft. office and distribution center including DEA-approved capabilities for Schedule II-V controlled drug products. For more information, visit www.prasco.com.  


'/>"/>
SOURCE Prasco Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
2. Prasco and Stiefel Sign Distribution and Supply Agreement for Clobetasol Propionate Foam
3. Prasco to Market Authorized Generic of ZEGERID®
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... -- Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe and ... painful intercourse and other painful pelvic pain conditions such as pelvic floor ... ... ... -based start-up company, VuVatech LLC, fills a void in the women,s ...
(Date:7/10/2017)... , July 10, 2017  US medical equipment ... in 2021, according to Medical Equipment & ... by Freedonia Focus Reports. Continued increases in demand for ... aging of the population and supported by gains in ... equipment and supplies. New product introductions will also drive ...
(Date:7/10/2017)... , July 10, 2017  BDI Group subsidiary ... patient support services organization serving specialty pharmacies, home ... launch of four significant, value-added member programs designed ... better manage reimbursement and improve access and affordability ... therapies. ...
Breaking Medicine Technology:
(Date:7/26/2017)... Royal Oak, Michigan (PRWEB) , ... July 26, 2017 , ... ... the newly appointed Medical Director for the treatment program located in Royal Oak, Michigan. ... a group of investors who are focused on providing the highest standards in the ...
(Date:7/26/2017)... ... July 26, 2017 , ... BioPlus ... released an updated version of the HCV Treatment Path app (version 4.4.0) to ... C virus (HCV) infection. All of the latest HCV medications are included in ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... sales department joining as Regional Account Manager for the Northeast and Florida regions. ... the liquidation of their obsolete medical assets. , Jennifer joins Centurion with a ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Spring Arbor University recently co-authored and published an article in the medical science ... Brachial Plexus Palsy. Both the article and the research that helped produce it, ...
(Date:7/25/2017)... Texas (PRWEB) , ... July 25, 2017 , ... ... Gold Winner for its Product Innovation in the prestigious CEO World Awards®. The ... organizational performance, new products and services, CEO case studies, corporate social responsibility, and ...
Breaking Medicine News(10 mins):